Inventiva (IVA) Change in Acquisitions & Divestments (2021 - 2025)

Inventiva (IVA) recorded quarterly Change in Acquisitions & Divestments of -$28.0 million in Q2 2025, down 515.45% quarter-over-quarter from $6.7 million in Q4 2021.

Inventiva (IVA) Change in Acquisitions & Divestments (2021 - 2025) Analysis & Trends

Inventiva's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at -$28.0 million for Q2 2025.

  • In Q2 2025, Change in Acquisitions & Divestments changed N/A year-over-year to -$28.0 million; the TTM figure through Jun 2025 stood at -$14.2 million (changed N/A YoY), while the FY2025 annual figure was -$133865.0, down 101.39% from the prior year.
  • Change in Acquisitions & Divestments was -$28.0 million for Q2 2025 at Inventiva, down from $6.7 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $9.0 million in Q1 2021 to a low of -$28.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Inventiva 8.52 Mn -260.21 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 -28.01 Mn
Jun 30, 2025 -28.01 Mn
Dec 31, 2021 6.74 Mn
Dec 31, 2021 6.74 Mn
Jun 30, 2021 -1.89 Mn
Jun 30, 2021 -1.89 Mn
Mar 31, 2021 9.00 Mn
Mar 31, 2021 9.00 Mn